HAL (France)open access
Retrospective, real‐life study of venetoclax plus azacitidine or low‐dose cytarabine in French patients with acute myeloid leukemia ineligible for intensive chemotherapy
0, Acute myeloid leukemia, 2, Low-dose cytarabine, Azacitidine, 1, Venetoclax
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 175708
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.